Navigation Links
Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
Date:11/3/2010

BASKING RIDGE, N.J., Nov. 3, 2010 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at IMPACT 2010 held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania.  Ms. McDonald's presentation will be given at 11:13 a.m. EST on Wednesday, November 10 in the Life Science Room #106AB and will include an overview of the Company's pipeline with emphasis on the lead development program, the innovative anticoagulant system, REG1.  As the oldest and most established venture conference in the Northeast, IMPACT 2010 continues to offer topical speakers, relevant panel sessions, cutting-edge company presentations, unparalleled networking and visibility opportunities for both attendees and sponsors alike.

ABOUT REGADO BIOSCIENCESRegado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrombotics, uniquely concomitantly minimizing the risk of ischemia and bleeding, and, by allowing patient specific tuning of the desired therapeutic effect, providing a safe and unique approach to personalized medicine.

ABOUT REG1, REG2 and REG3 &
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
2. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
3. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
4. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
5. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
6. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
7. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
8. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
9. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
10. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Mass. , March 3, 2015 Boston Scientific ... Charles J. Dockendorff and Stephen P. MacMillan ... Two current members of the board, Uwe E. Reinhardt ... for re-election at the company,s annual meeting of stockholders in ... was formerly the executive vice president and chief financial officer ...
(Date:3/3/2015)... , March 3, 2015   Surefire ... a prospective clinical trial comparing the Surefire Infusion System ... either primary or metastatic liver cancer, using the ... uptake of embolic agents, and with significantly decreased ... presented today at the Society of Interventional ...
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ... POC Diagnostics Market 2015-2019" report to their offering. ... POC Diagnostics market to grow at a CAGR of ... POC diagnostics are IVD devices and tools used for ... The use of these devices helps in the rapid ...
Breaking Medicine Technology:Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 2Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2
... 2007 - Pro-Pharmaceuticals,Inc. (Amex: PRW), a developer ... Eliezer Zomer, Ph.D., Executive Vice,President, Product Development ... Advanced Solid Tumors of,5-FU with an Admixture ... of Oncodevelopmental Biology and Medicine,(ISOBM) Conference to ...
... Investigative Dermatology, FREEPORT, N.Y., May 16, 2007 ... clinical data that indicates,that OCTN-1 skin cells ... L-ergothioneine (EGT) as a protector against oxidative,damage, ... more powerful and,efficient antioxidant than idebenone, scavenging ...
Cached Medicine Technology:Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 2Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 3Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 5AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
(Date:3/3/2015)... 2015 The biggest name in indoor ... the world’s first fully integrated air quality platform that ... an air purifier to remove dust, pollen and hazardous ... control, via phone, tablet or computer. , Sweden’s Blueair, ... countries worldwide, will unveil its Internet-enabled air sensor together ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 The ... the public’s expectation of excellence in care and safe ... the position of the RNS that biologic infusions are ... under the direct supervision of a registered nurse (RN), ... reactions, including anaphylaxis can occur in patients receiving these ...
(Date:3/3/2015)... 2015 In March, 1% for the ... kick off a new campaign, “Know Your Source,” which calls ... and ambassadors in their quest for ingredient awareness and better ... of its members and partners, including King Arthur Flour, Good ... to raise awareness for food as an environmental issue, with ...
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 2015? ... Alopecia is the loss of hair. Alopecia areata and ... Causes for alopecia include aging, genetics, illness, chemotherapy, malnutrition ... pattern hair loss, female diffuse hair loss, hairs easily ... focal or diffuse and by the presence or absence ...
(Date:3/3/2015)... US Air Purifiers LLC , an ... is pleased to announce that all Rabbit brand air purifiers ... to the west coast port strikes. This news comes just ... , The port strikes, which have caused ... quarter economic growth by as much as 1%, have hindered ...
Breaking Medicine News(10 mins):Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3
... was halted early after risk of both recurrence and ... -- European researchers report more grim news concerning women ... run the risk of developing breast cancer while taking ... face a higher risk of a recurrence or a ...
... to be published in the American Journal of,Epidemiology, ... publication in the American Journal of Epidemiology, a team ... Michigan found,that women who ate the most fish (more ... pregnancies delivered children with the highest,scores on two cognitive ...
... year when more,than 1.5 million high school and college students ... large quantities of alcohol. Students who,vacation with friends over spring ... home with parents or relatives, according to a report in ... and Drugs., Instead of just telling students not to ...
... HILL, N.C., March 25 Successful brand leaders,know ... crucial and effective,strategies to optimize a product,s lifecycle., ... Promotion in,segmented sectors, and Clinical and Scientific Excellence ... a brand,s success and describes exactly,which costs need ...
... whites, study finds , , TUESDAY, March 25 (HealthDay News) -- ... blacks are much less likely to get colonoscopies than their ... who have an increased chance of developing colon cancer continue ... lack of a doctor referral stood out as the primary ...
... NEW YORK, March 25 For journalists covering,today,s release ... and,Medicare assessing the fiscal health of the government,s two ... budget),the authors of a popular book on the federal ... question: Are America,s leaders so immersed in,short term political ...
Cached Medicine News:Health News:HRT Raises Recurrence Risk Among Breast Cancer Survivors 2Health News:Study: Pregnant Women Who Eat More Fish, Including Canned Tuna, Have Smarter Children 2Health News:It's Spring Break: How Much Does Heavy Drinking Affect Your Body? 2Health News:Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance 2Health News:High-Risk Blacks Less Likely to Get Colonoscopies 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: